Teva R&D Philosophy and Capabilities
Since 1901, we have been committed to helping to improve the lives of patients through rigorous and innovative scientific research. This defines how we do business and how we approach medicine. We will continue to invest in new breakthrough treatments, offer innovative solutions, and find new ways to extend and expand patient care beyond medicine. We understand the many ways that health impacts people’s lives. We provide research-based resources beyond medicines to help patients, caregivers, and communities live healthier every day.
This holistic approach and unique structure brings fresh thinking, different perspectives, and broader knowledge into our research and development process. It encompasses our expertise in devices, in formulation and in analytics. These are combined with deep therapeutic understanding and outstanding clinical and non-clinical development skills. Together, this enables us to create new treatments that integrate with patients’ needs and ultimately help make lives better. Teva is committed to ensuring patient safety, managing regulatory compliance, tracking safety data and fulfilling pharmacovigilance requirements for our medicines worldwide.
With our unique integrated drug development model, Teva’s Global R&D organization helps propel the company’s mission to be a global leader in generics and biopharmaceuticals. From early development to commercial launch of small molecules, novel biologics and biosimilars, our “One Teva” R&D approach combines our strength in generics with our knowledge of innovative drug development. We leverage in-house expertise across our generics and specialty pipelines to unlock synergies and gain efficiencies that deliver high-quality, innovative treatments to patients.
Our dedicated researchers are focused on improving patient health through the application of the most up-to-date research technology and techniques. Teva’s R&D group has an exceptional track record in translating early drug opportunities into clinically-proven drug candidates by using cutting edge research in facilities that are fully equipped to support both good laboratory practice (GLP) and current good manufacturing practice (cGMP) regulations. Thanks to our research and development technology, our treatment deliveries have expanded beyond tablets, capsules, liquids, ointments and creams to a broad range of dosage forms and delivery systems. These include drug-device combination products, long acting release injectables, transdermal patches and films, and nasal suspensions.
As we work tirelessly to challenge unmet patient needs, our focus remains to understand current and future healthcare challenges and apply new technologies in an innovative and thoughtful manner to meet them. Through this company-wide commitment, we look to secure our position as a world leader in the development of healthcare solutions meeting the needs of patients today and tomorrow.